The stock of Concordia International Corp (TSE:CXR) is a huge mover today! About 298,016 shares traded hands. Concordia International Corp (TSE:CXR) has declined 89.24% since April 20, 2016 and is downtrending. It has underperformed by 94.65% the S&P500.
The move comes after 7 months positive chart setup for the $157.58 million company. It was reported on Nov, 24 by Barchart.com. We have $3.86 PT which if reached, will make TSE:CXR worth $12.61M more.
Concordia International Corp (TSE:CXR) Ratings Coverage
Out of 4 analysts covering Concordia Healthcare Corp (TSE:CXR), 0 rate it a “Buy”, 0 “Sell”, while 4 “Hold”. This means 0 are positive. $135 is the highest target while $2 is the lowest. The $28.40 average target is 695.52% above today’s ($3.57) stock price. Concordia Healthcare Corp has been the topic of 26 analyst reports since August 11, 2015 according to StockzIntelligence Inc. Goldman Sachs maintained the shares of CXR in a report on Friday, July 22 with “” rating. The stock of Concordia International Corp (TSE:CXR) has “Outperform” rating given on Monday, June 20 by RBC Capital Markets. The rating was maintained by RBC Capital Markets with “Outperform” on Tuesday, June 7. RBC Capital Markets maintained the shares of CXR in a report on Monday, May 16 with “Outperform” rating. The stock has “Outperform” rating given by RBC Capital Markets on Tuesday, August 11. The stock has “Sector Outperform” rating given by Scotia Capital on Wednesday, September 9. RBC Capital Markets maintained Concordia International Corp (TSE:CXR) rating on Tuesday, October 11. RBC Capital Markets has “Outperform” rating and $18.50 price target. The rating was maintained by RBC Capital Markets with “Outperform” on Friday, January 8. The firm has “Outperform” rating given on Monday, October 24 by RBC Capital Markets. The rating was maintained by RBC Capital Markets on Monday, October 31 with “Outperform”.
More recent Concordia International Corp (TSE:CXR) news were published by: Prnewswire.com which released: “Concordia International Corp. Announces CEO Transition Plan” on October 21, 2016. Also Prnewswire.com published the news titled: “Concordia International Corp. Announces Communication With CMA” on October 25, 2016. Prnewswire.com‘s news article titled: “Shareholder Class Action Filed Against Concordia International Corp. – CXRX” with publication date: August 17, 2016 was also an interesting one.
Concordia International Corp, formerly Concordia Healthcare Corp, is a Canada pharmaceutical company. The company has a market cap of $157.58 million. The Company, through subsidiaries, owns a portfolio of branded and generic prescription products. It currently has negative earnings.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.